Metraipolis › archive › dc_beb3db937495
N-(2-Hydroxyphenyl)-2-propylpentanamide Modulates HDAC1 and GPER1 Expression in a Rodent Model of Triple-Negative Breast Cancer — Europe PMC PMID:41751221
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41751221
- DOI
- 10.3390/biomedicines14020322
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T09:56:09.019Z
- SHA-256 of the archived text
c12071bce7c3593c28864c2503968e37b85ba553ecabad057adc199d06e30667- Stable URL of this page
https://metraipolis.com/documento/dc_beb3db937495
How to cite
N-(2-Hydroxyphenyl)-2-propylpentanamide Modulates HDAC1 and GPER1 Expression in a Rodent Model of Triple-Negative Breast Cancer — Europe PMC PMID:41751221 — Europe PMC (en), https://europepmc.org/article/MED/41751221 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_beb3db937495 (Metraipolis archive dc_beb3db937495, sha256 c12071bce7c3593c28864c2503968e37b85ba553ecabad057adc199d06e30667)
BibTeX
@misc{dcbeb3db937495,
title = {N-(2-Hydroxyphenyl)-2-propylpentanamide Modulates HDAC1 and GPER1 Expression in a Rodent Model of Triple-Negative Breast Cancer — Europe PMC PMID:41751221},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41751221},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_beb3db937495; sha256 c12071bce7c3593c28864c2503968e37b85ba553ecabad057adc199d06e30667},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41751221. Agents can read the archived copy with the MCP tool read_document.